Advertisement
MTD vs SYK
Which Stock Would AI Choose? Mettler-Toledo International Inc. (MTD) vs. Stryker Corporation (SYK) Stock Comparison
Key Takeaways
- MTD has outperformed SYK on a year-to-date basis with an 8.57% gain compared to SYK's 6.14%, driven by recent share price recovery.
- MTD trades at a lower trailing P/E (price-to-earnings) ratio of 30.31 versus SYK's 39.17, suggesting relatively better valuation amid similar sector exposure.
- Both stocks approach Q1 2026 earnings, with MTD expected to report EPS of $8.70 (up 6.2% YoY) on May 7 and SYK anticipating $2.98 EPS alongside revenue growth.
- SYK boasts a larger market cap of $126B and revenue base of $25.12B, contrasting MTD's $25.81B cap and $4.03B sales, highlighting scale differences.
- MTD exhibits higher profit margins at 21.59% versus SYK's 12.92%, but SYK offers a dividend yield of 1.07% while MTD pays none.
- Analyst consensus leans "Moderate Buy" for both, with SYK's average price target implying greater upside potential from current levels.
Introduction
Mettler-Toledo International Inc. (MTD) and Stryker Corporation (SYK) operate in the precision instruments and medical technology sectors, serving overlapping needs in healthcare, pharmaceuticals, and laboratory applications. This comparison is relevant for investors seeking exposure to medtech and scientific equipment amid evolving market dynamics, including supply chain resilience and innovation in diagnostics. Traders focused on relative performance may find value in analyzing their momentum divergence, valuation metrics, and upcoming catalysts like quarterly earnings. Both stocks offer insights into sector trends without direct competition, aiding portfolio diversification decisions in a volatile environment.
MTD Overview and Recent Performance
Mettler-Toledo International Inc. (MTD) is a global leader in precision instruments and services for laboratory, industrial, and food retailing applications, including balances, pipettes, and analytical systems used in pharmaceuticals and biotech. In recent market activity, MTD's shares have traded around $1,275, within a 52-week range of $1,029 to $1,525, reflecting resilience after earlier dips. Year-to-date gains stand at 8.57%, bolstered by a 20.05% one-year return, amid anticipation for Q1 2026 earnings on May 7 where EPS is projected at $8.70, up 6.2% year-over-year. Sentiment has shifted positively due to recovery from oversold conditions and inclusion in wide-moat portfolios, though higher beta (1.43) signals volatility tied to research tool demand.
SYK Overview and Recent Performance
Stryker Corporation (SYK) specializes in medical technologies, particularly orthopaedics, surgical equipment, and neurotechnology, with products like joint replacements and endoscopy systems serving hospitals worldwide. Recent weeks have seen shares hover near $329, in a 52-week band from $319 to $405, with YTD performance at 6.14% and one-year gains of 9.01%. A cyberattack highlighted cybersecurity risks, yet robust Q4 2025 results—with record $25.1B annual revenue—support optimism ahead of Q1 2026 earnings around late April. Lower beta (0.93) underscores stability, influenced by steady procedure volumes and robotics adoption, though recent share weakness tempers enthusiasm.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases 25 top-performing AI trading bots curated from over 351 available models that trade thousands of tickers across stocks, ETFs, and crypto. These bots employ diverse strategies, timeframes (from 5-minute to 60-minute charts), and volatility preferences (low to high), adapting to current market conditions for optimal suitability. While specific performance stats like win rates or profit factors vary by bot, the selection emphasizes those demonstrating consistency in recent trends. Investors can explore these automated tools to enhance trading efficiency without manual oversight. Visit the page to identify bots potentially suited for MTD or SYK exposure.
Head-to-Head Comparison
MTD focuses on lab and industrial precision tools, contrasting SYK’s emphasis on clinical devices like implants, creating complementary rather than competitive dynamics in healthcare. Growth drivers differ: MTD leverages high-margin pharma demand (21.59% profit margin), while SYK scales via acquisitions and ortho procedures (11.4% quarterly revenue growth YoY). Recent momentum favors MTD’s 20% one-year advance over SYK’s 9%, but SYK’s $126B market cap dwarfs MTD’s $26B, offering liquidity trade-offs. Risk profiles highlight MTD’s elevated beta and no dividend versus SYK’s stability and 1.07% yield. Sector exposure ties both to medtech sentiment, yet MTD’s superior ROA (20.35%) edges SYK’s (7.92%), balancing valuation pressures from higher SYK P/E.
Tickeron AI Verdict
Tickeron’s AI currently leans toward MTD based on stronger trend consistency, recent momentum outperformance, and more attractive P/E positioning relative to growth prospects. SYK’s scale and catalysts provide a close contest, suggesting probabilistic edge for MTD in short-term relative positioning amid earnings anticipation.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTD is a Hold and SYK is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MTD’s FA Score shows that 1 FA rating(s) are green whileSYK’s FA Score has 1 green FA rating(s).
- MTD’s FA Score: 1 green, 4 red.
- SYK’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MTD’s TA Score shows that 4 TA indicator(s) are bullish while SYK’s TA Score has 4 bullish TA indicator(s).
- MTD’s TA Score: 4 bullish, 4 bearish.
- SYK’s TA Score: 4 bullish, 3 bearish.
Price Growth
MTD (@Medical Specialties) experienced а +0.31% price change this week, while SYK (@Medical/Nursing Services) price change was +0.71% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.17%. For the same industry, the average monthly price growth was +8.92%, and the average quarterly price growth was -2.29%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +23.45%. For the same industry, the average monthly price growth was +12.35%, and the average quarterly price growth was -13.81%.
Reported Earning Dates
MTD is expected to report earnings on Jul 23, 2026.
SYK is expected to report earnings on Jul 30, 2026.
Industries' Descriptions
@Medical Specialties (-1.17% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (+23.45% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| MTD | SYK | MTD / SYK | |
| Capitalization | 23.1B | 118B | 20% |
| EBITDA | 1.25B | 6.44B | 19% |
| Gain YTD | -17.885 | -12.188 | 147% |
| P/E Ratio | 26.89 | 35.63 | 75% |
| Revenue | 4.09B | 25.3B | 16% |
| Total Cash | 60.6M | 2.97B | 2% |
| Total Debt | 2.23B | 14.7B | 15% |
MTD | SYK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 80 | 72 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 9 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 67 | |
SMR RATING 1..100 | 2 | 57 | |
PRICE GROWTH RATING 1..100 | 57 | 62 | |
P/E GROWTH RATING 1..100 | 59 | 80 | |
SEASONALITY SCORE 1..100 | 50 | 41 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SYK's Valuation (9) in the Medical Specialties industry is significantly better than the same rating for MTD (99). This means that SYK’s stock grew significantly faster than MTD’s over the last 12 months.
SYK's Profit vs Risk Rating (67) in the Medical Specialties industry is somewhat better than the same rating for MTD (100). This means that SYK’s stock grew somewhat faster than MTD’s over the last 12 months.
MTD's SMR Rating (2) in the Medical Specialties industry is somewhat better than the same rating for SYK (57). This means that MTD’s stock grew somewhat faster than SYK’s over the last 12 months.
MTD's Price Growth Rating (57) in the Medical Specialties industry is in the same range as SYK (62). This means that MTD’s stock grew similarly to SYK’s over the last 12 months.
MTD's P/E Growth Rating (59) in the Medical Specialties industry is in the same range as SYK (80). This means that MTD’s stock grew similarly to SYK’s over the last 12 months.
| MTD | SYK | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 75% | N/A |
| Stochastic ODDS (%) | 3 days ago 57% | 3 days ago 60% |
| Momentum ODDS (%) | 3 days ago 63% | 3 days ago 52% |
| MACD ODDS (%) | 3 days ago 59% | 3 days ago 59% |
| TrendWeek ODDS (%) | 3 days ago 61% | 3 days ago 54% |
| TrendMonth ODDS (%) | 3 days ago 59% | 3 days ago 52% |
| Advances ODDS (%) | 20 days ago 61% | 16 days ago 55% |
| Declines ODDS (%) | 4 days ago 65% | 10 days ago 53% |
| BollingerBands ODDS (%) | 3 days ago 70% | 3 days ago 81% |
| Aroon ODDS (%) | 3 days ago 61% | 3 days ago 44% |
Advertisement
MTD and
Correlation & Price change
A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.
| Ticker / NAME | Correlation To MTD | 1D Price Change % | ||
|---|---|---|---|---|
| MTD | 100% | +1.36% | ||
| A - MTD | 71% Closely correlated | +2.20% | ||
| TMO - MTD | 67% Closely correlated | +0.63% | ||
| BRKR - MTD | 67% Closely correlated | +4.57% | ||
| DHR - MTD | 63% Loosely correlated | -0.33% | ||
| AZTA - MTD | 61% Loosely correlated | +2.80% | ||
More | ||||
SYK and
Correlation & Price change
A.I.dvisor indicates that over the last year, SYK has been loosely correlated with ISRG. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SYK jumps, then ISRG could also see price increases.